Piramal Pharma Approves Grant of 56 Lakh Stock Options Under Employee Incentive Plan 2022
The Nomination and Remuneration Committee of the Board of Directors at Piramal Pharma Limited has approved the grant of stock options under the Employee Stock Option and Incentive Plan 2022. The decision was made during a meeting held on Wednesday, July 29, 2026.The company granted up to 56,36,436 stock options as part of the incentive plan. These options are structured according to SEBI (SBEB) Regulations, 2021. The grant was made at an exercise price of Rs.10/- per option and covers a total of 56,36,436 equity shares.
Key details regarding the stock option grant include:
| Feature | Details |
|---|---|
| Options Granted | 56,36,436 under Employee Stock Option and Incentive Plan 2022 |
| Exercise Price per Option | Rs.10/- |
| Total Shares Covered | 56,36,436 equity shares |
The vesting schedules are segmented based on the jurisdiction of the options. Options not designated for the US market have specific tranche-based vesting and exercise timelines.
For domestic options (excluding US), the granting structure includes three potential vesting tranches:
- One-third would vest on July 29, 2027, and be exercisable until July 28, 2032.
- One-third would vest on July 29, 2028, and be exercisable until July 28, 2033.
- One-third would vest on July 29, 2029, and be exercisable until July 28, 2034.
Alternative domestic vesting structures include a two-thirds tranche vesting on July 29, 2027 (exercisable till July 28, 2032) and one-third vesting on July 29, 2028 (exercisable till July 28, 2033). Another structure involves a 70% tranche vesting on July 29, 2027 (till July 28, 2032) and 30% vesting on July 29, 2028 (till July 28, 2033).
The US options have their own set of vesting tranches: one-third would vest on July 29, 2027, and be exercisable until March 15, 2028; a second third on July 29, 2028, with an exercise deadline of March 15, 2029; and the final third on July 29, 2029, with an exercise period extending to March 15, 2030.
Options may be exercised within five years commencing from the date of vesting for all tranches. For US vested options, the exercise must occur within the specific periods detailed in the plan.
PPLPHARMA Stock Price Movement
Piramal Pharma Limited shares today edged higher to close at ₹195.68, gaining 0.81%. The stock saw robust market activity as a total traded volume of 11.84 million shares was recorded during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.